You are here

  • Home
  • Archive
  • Volume 64, Issue 1
  • Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial—ANRS HB02 VAC-ADN

Citation Tools

Article menu
Download PDFPDF
Hepatology
Original article
Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial—ANRS HB02 VAC-ADN

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Fontaine H, Kahi S, Chazallon C for the ANRS HB02 study group, et al
Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial—ANRS HB02 VAC-ADN
Gut 2015;64:139-147.